The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
A recent study investigated muscle function in people with hip ... Researchers Seek to Improve Advanced Pain Management Using AI for Drug Discovery Oct. 4, 2024 — An estimated one in five ...
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
Starting with research she conducted at BC’s Connell School of Nursing, she has become a national expert on pain management for those who have suffered from substance abuse. She’s published papers on ...
A pain management physician and his medical practice will pay $3.5 million, among other penalties, to resolve allegations of billing for medically unnecessary testing and pre-signing opioid ...
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...